What are the effects of Sorafenib Tosylate Tablets?

Sorafenib (Sorafenib) mainly exerts its therapeutic effect by inhibiting multiple signaling pathways in tumor cells. It can inhibit the Raf/MEK/ERK protein kinase in tumor cells and block the activation of this signaling pathway, thereby inhibiting the proliferation and growth of tumor cells; inhibiting tumor cells It contains vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR), thereby reducing angiogenesis and blood supply, reducing the nutrient supply and oxygen supply of tumors. Sorafenib can also promote tumor cell death by activating the apoptosis pathway, reduce the invasion and metastasis ability of tumor cells, and reduce the risk of distant metastasis of tumors.